Saturday, February 18, 2006


Hep C Virus - Hepatitis C Virus Lives In Your Liver(NC)-Your liver

Hepatitis C Virus Lives In Your Liver

(NC)-Your liver works 24 hours a day, performing over 500 vital functions for your body. Most of the blood that returns to your heart passes through the liver. Your body can't function without it.

The hepatitis C virus lives in your liver. It inflames liver cells, which, over time, affects the way your liver functions. The effect of the hepatitis C virus varies from person to person. There is no way to predict how your body will react to it. There are, however, some things that are known:

You can live with hepatitis C for many years without experiencing any major symptoms, or you might simply feel tired. Symptoms can come and go over time. Their presence or absence does not tell you the degree to which liver damage may or may not be occurring. p>

Chronic, long-term inflammation of the liver can cause liver cell damage and result in fibrosis (liver scarring), or even cirrhosis. This damage can occur in as little as five years, or as long as 30 years.

About 20% of chronic hepatitis patients develop cirrhosis within 10 to 20 years.

Use of recreational drugs or alcohol can speed up inflammation and the development of fibrosis or cirrhosis.

There is an increased risk of liver cancer in people with cirrhosis.

The good news is that current drug treatments can be very effective for people with hepatitis C. Combined with proper nutrition, plenty of rest, and avoidance of recreational drugs and alcohol, these treatments help many who have the virus lead relatively healthy lives.

If you think you may be at risk of getting hepatitis C, see your doctor. The virus can be detected by a simple blood test. For more information on how to keep your liver happy and healthy, visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

p>

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services. p>



Hep C Virus - Landmark FSU Study Of Hepatitis C Virus Solves Mystery That Has Stymied Quest For Cure


Landmark FSU Study Of Hepatitis C Virus Solves Mystery That Has Stymied Quest For Cure
Medical News Today - Feb 08 7:03 PM
The hepatitis C virus (HCV) infects more than 170 million people worldwide and leads to both acute and chronic liver diseases. Since its discovery several decades ago, the insidious human pathogen has stymied the quest for anti-viral therapies by refusing to reproduce in test tubes for more than a few hours or days, denying scientists an efficient virus production and infection system for Save to My Web

Roth Capital Partners 18th Annual Growth Stock Conference Presenter Profiles
RedNova - Feb 17 1:09 PM
Roth Capital Partners 18th Annual Growth Stock Conference takes place Feb. 20-22 at the St. Regis Monarch Beach Resort & Spa in Dana Point, Calif. For in-depth information about the event visit http://www.rothcp.com/index06%20DP.html.Save to My Web

Benitec Delays IND Filing for HIV/AIDS Therapeutic Pending Resolution Of Manufacturing Result
[Press Release] PR Newswire via Yahoo! Finance - Jan 31 5:30 AM
Benitec Ltd. , a leading developer of RNA interference -based therapeutics, announced today that the Investigational New Drug filing with the US Food & Drug Administration for its HIV/AIDS therapeutic will be delayed.Save to My Web

Benitec Appoints Two New Directors
[Press Release] PR Newswire via Yahoo! Finance - Feb 09 5:30 AM
Benitec Ltd. , a leading developer of RNA interference -based therapeutics, announced today that it has appointed Peter Francis as a Non-executive Director and Michael Catelani as an Executive Director of its Board.Save to My Web

Friday, February 17, 2006


Hep C Virus - National Hepatitis C Coalition


National Hepatitis C Coalition
Volunteer nonprofit organization dedicated to providing information and support to hepatitis patients, families, and friends, through grassroots support groups.

Hepatitis C
Hepatitis C. By Howard J. Worman, M. D. The Hepatitis C Virus (HCV) HCV was discovered in 1989 by investigators at Chiron, Inc.

Special Medical Reports - March 1, 1999 - American Academy of Family Physicians
... Treatment is recommended for patients with chronic hepatitis C infection who are at greatest risk for progression to ...

Hep C Virus - Living Well with Hepatitis C Virus Infection - BC HealthFile #40b


Living Well with Hepatitis C Virus Infection - BC HealthFile #40b
Symptoms of acute hepatitis C infection may include: fever, tiredness, jaundice [yellow skin or eyes], abdominal pain, dark urine, loss of appetite, ...

Hepatitis C
Hepatitis C. By Howard J. Worman, MD. NEW: The Hepatitis C Sourcebook. By Howard J. Worman, MD. The Hepatitis C Virus (HCV) ...

If You Have Hepatitis C Infection - Liver Health Information - The ...
If You Have Hepatitis C Infection. By ALF in collaboration with the Veterans Affairs Centers of Excellence in Research and Education for Hepatitis C ...

Hep C Virus - Treating Chronic Mutational Hepatitis B with Chinese Medicine

Treating Chronic Mutational Hepatitis B with Chinese Medicine Vitalliver (Vigconic Suppositories)


Treating chronic mutational hepatitis B with Chinese medicine Vitalliver (Vigconic suppositories)


ZHANG GUAN HUA, LIANG CHAO, ZHENG WAN PIN


Chengdu University of TCM, Hepatitis Laboratory in the attached hospital of Chengdu University of TCM, Sichuan, China

Research Method:

Quantitative determination by contrasting HBV-DNA of cases before and after the treatment.

Number of cases: 25 (n)

Case Selection: Between the age of 16 and 65, in accordance with the diagnosis standards pf chronic Hepatitis B, with negative e antigen and positive e antibody, HBV-DNA > 1 104 cp/mL.

Detection Method: All the blood samples are detected by Sichuan Clinical Detection Center; PCR-ELISA quantitative determination is used within detection range of 1 104 - 1 107-8, HBV-DNA, unit of measurement is cp/mL.

Direction Plan: one suppository provided by Vigconic (International) Ltd. Bid. The course of treatment is six months, the tracing observation after withdrawal lasts six months.

Observation index:


  1. HBV-DNA response after the treatment.

  2. Lasting HBV-DNA response (six months after withdrawal).
    p>

Criterion of Therapeutic Effect:


  1. If HBV-DNA volume 1 104 cp/mL: 4/25 (16%)

  2. Lasting response:


HBV-DNA volume 1 104 cp/mL: 2/25 (8%)

Among the results of lasting response, 16 blood serum samples are detected through fluorimetric quantitative determination PCR by the instruments of PE.USD, H-7700 in the second attached hospital of Guangzhou Medical College. The result is in accordance with that in Sichuan Clinical Testing Center. (8 cases among it 1 102 cp/mL). The testing range of this testing method is 1 102 - 1 107-8 cp/mL.

Conclusion

The reason for the repeatedly abnormal liver function of Chronic Hepatitis B (CHB) patients lies in the repeatedly duplication of HBV after infection, which leads to fibrosis of liver, then cirrhosis and liver cancer. It is commonly accepted that if CHB shows the transformation of HBeAg/Anti-HBe, HBV-DNA becoming negative, liver function returning to normal state, the disease is relieved. However, parts of patients with the transformation of HBeAg/Anti-HBe still remain positive in HBV-DNA and the pathological change in the liver continues. Because HBV-DNA occurs promoter mutation in the anterior C section (1896 necleoside G-A variation) or in the C section (1762 nucleoside T variation, 1764 G-A variation), HBeAg cannot come into being. Therefore, the HBeAg in the patient s blood cannot be detected, while the virus can keep on duplicating and fixing itself. Through sequential assay of nucleic acid, it proves that promoter mutation appears in 30%-60% of HBeAg negative Chronic Hepatitis B (CHB) in the anterior C section or in the C section. In some provinces and cities of the People of China, the percentage of promoter mutation appears in HBeAg negative Chronic Hepatitis B (CHB) in the anterior C section or in the C section is from 17.6% to 78.9%. Eight out of the 25 cases of our observation go through the sequential assay of nucleic acid carried out by the Department of Microbiology of the University of Hong Kong. It all proves to have HBV-DNA mutation. The chronic mutational Hepatitis B is infectious and apt to cause cirrhosis and liver cancer since the present medicines of antivirus and immuno-modulator do not produce the expected therapeutic effects.

Vitalliver suppository is made up from a formula of Chinese herbs, including Ginseng, Deer Horn, Cordyceps, Radix Astragali, Frudctus Cnidii, Semen Cuscutae, etc. The formula is mainly for strengthening the body resistant and primarily for reinforcing Kidney Qi, which produces good therapeutic effects in treating chronic mutational Hepatitis B. The mechanism is probably that through the regulating of immune system, the duplication of virus is inhibited and meanwhile the liver is protected, so it can produce a lasting therapeutic effect. No adverse reaction and severe accident happens during clinical observation, so it is safe for using. Vitalliver is bringing hopes to the treatment of chronic mutational Hepatitis B.

* The second stage of clinical trial would be carrying out by the Microbiology Department of the University of Hong Kong and Chengdu University of Traditional Chinese Medicine.

For more information, please visit: http://www.vigconic.com


Or, contact:


William Yip cs@vigconic.com
p>
5/F, Cheung Wah Building, Sheung Heung Rd,


Kowloon, Hong Kong


Tel: 852-27656200


Fax: 852-27645314
p>

Chengdu University of TCM, Hepatitis Laboratory in the attached hospital of Chengdu University of TCM, Sichuan, China


webmaster@vigconic.com

Thursday, February 16, 2006


Hep C Virus - MedMira Rapid Test


MedMira Rapid Test
The start of the New Year was accompanied by the European Patent Office granting a patent for a rapid HCV test. Now that the technology is here, let's hope the test proves accurate, with high levels of selectivity and specificity....

Vaccination Tames Hepatitis A Infection
Title: Vaccination Tames Hepatitis A InfectionCategory: Health NewsCreated: 7/13/2005 1:58:00 AMLast Editorial Review: 7/13/2005 1:58:14 AM

How to Choose a Doctor
Title: How to Choose a DoctorCategory: Doctor's ViewsCreated: 6/17/2005Last Editorial Review: 8/9/2005

Pill Form of Therapy for HCV Coming Closer
This report is an update of therapy progress presented at the AASLD (American Academy for the Study of Liver Diseases). Three separate approaches are covered. Yes, progress is being made....

Hep C Virus - My dad was dying and we never knew


My dad was dying and we never knew
Norfolk Eastern Daily Press, UK - Jan 26, 2006... This include raising awareness of groups that may have been at past risk of hepatitis C infection including recipients of blood transfusion before donor ...

Enzo Biochem Shareholders Elect Three Directors at Annual Meeting
Genetic Engineering News, NY - Jan 19, 2006... of its proprietary gene medicine for HIV-1 infection and its proprietary immune regulation medicines for hepatitis B and hepatitis C infection and for Crohn's ...

Transgene Awarded EUR 1.3 M Grant for Hepatitis C Therapeutic ...
Canada NewsWire (press release), Canada - Jan 25, 2006... About Hepatitis C: Hepatitis C infection is a major public health problem with around 170 to 200 million people infected worldwide. ...

HAART reduces liver-related death risk, but hepatitis C infection ...
Aidsmap, UK - Jan 18, 2006Highly active antiretroviral therapy (HAART) reduces the risk of liver-related death by 68%, although infection with both HIV and hepatitis C virus (HCV ...

Peregrine accelerates Tarvacin development
Pharmaceutical Business Review - Jan 19, 2006... Peregrine. In the phase I trial, a single dose of Tarvacin is being tested in patients with chronic hepatitis C infection. Data ...

Wednesday, February 15, 2006


Hep C Virus - Farrar rebuilds a no-frills Son Volt


Farrar rebuilds a no-frills Son Volt
San Jose Mercury News - If you've seen Jay Farrar onstage - be it with alt-country favorite Uncle Tupelo, with the early version of Son Volt, or on his own - you know this is an artist not exactly prone to outbursts of laughter. A seemingly stoic vocalist, Farrar has

Defence says it lacks disclosure of witnesses as tainted-blood case
Macleans - TORONTO (CP) - The criminal trial involving the man at the centre of the tainted-blood scandal began Monday with defence lawyers accusing the Crown of attempting to bombard the court with expert witnesses to turn the case into "a public inquiry

Woman: Illegal body piercing causing hepatitis
Times and Democrat - A local businesswoman who wants to offer tattoos claims that Orangeburg County has 17 documented cases of hepatitis C caused by illegal body piercing. Speaking to Orangeburg County Council Monday night, Tammy Conner said most of the cases are

BioCryst to Present at the BIO CEO & Investor Conference 2006
dBusinessNews.com - BIRMINGHAM -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that it will present at the BIO CEO & Investor Conference 2006 on Wednesday, February 15, 2006 at 1:00 p.m. Eastern Time at the Waldorf Astoria Hotel in New York City. The

Experimental hepatitis C treatment shows promise
Advocate - Biotech company Vertex Pharmaceuticals on Tuesday said a mid-stage clinical trial has shown its hepatitis C treatment lowered virus levels to undetectable levels. The Phase II trial enrolled 12 hepatitis C patients and dosed them with Vertex' VX-950

Hep C Virus - CDC: Viral Hepatitis C


CDC: Viral Hepatitis C
Includes information on prevention, testing, and risk factors, and management of HCV infection.

CIRRHOSIS IN CHRONIC HEPATITIS C INFECTION
CIRRHOSIS IN CHRONIC HEPATITIS C INFECTION. Jorge L. Herrera M.D. Division of Gastroenterology, University of South Alabama College of Medicine, Mobile AL. (pdf available, click here) Diagnosing cirrhosis ... Only the minority of patients with hepatitis C infection progress to cirrhosis. Studies have shown that 20% to 25 ...

Hepatitis C and Complementary and Alternative Medicine: 2003 Update
... small and on liver diseases rather than on hepatitis C infection specifically, and the results have been contradictory ...

Hep C Virus - HCV Overview : ViraCor Laboratories


HCV Overview : ViraCor Laboratories
A molecular diagnostic and research lab that offers quantitative results (viral loads) in 24 hours using Real Time PCR Technology ... Description. HCV is a member of the Flavivirus family.1 It is a single-stranded, positive-sense RNA ... spherical and lipid-enveloped.1 HCV was discovered in the late 1980s ...

HCV and Neuropathy
HCV and Neuropathy. Hepatitis C Virus Can Damage the Central Nerve System. It is generally believed that the hepatitis C virus can damage only liver and blood. ... al's 1999 review of a small series of HCV- infected patients showing neurological manifestations, a patient with ... also have been described in HCV-infected persons.11,12 In addition ...

SF AIDS Fdn: BETA Year-End 99 -- Natural History and Treatment of Hepatitis C
This article from the Year-End 99 Bulletin of Experimental Treatments for AIDS covers the natural history and treatment of hepatitis C. ... of people infected with the hepatitis C virus (HCV) develop chronic hepatitis, which may lead to fibrosis ... Because people with HCV often develop symptoms years-or even decades-after ...

ADA.org: Dental Topics: Hepatitis C Virus (HCV)
This page provides current information on the Hepatitis C Virus (HCV) as it relates to dental professionals. ... are infected with hepatitis C virus (HCV) - four times the number infected with human immunodeficiency virus (HIV). Chronic HCV increases the risk of developing serious ...

Tuesday, February 14, 2006


Hep C Virus - MedMira Rapid Test


MedMira Rapid Test
The start of the New Year was accompanied by the European Patent Office granting a patent for a rapid HCV test. Now that the technology is here, let's hope the test proves accurate, with high levels of selectivity and specificity....

Health Tip: Nail Salon Safety
Title: Health Tip: Nail Salon SafetyCategory: Health NewsCreated: 4/12/2005 1:59:00 AMLast Editorial Review: 4/12/2005 1:58:31 AM

Vitamins Suggested During Combination Therapy
A Japanese research study demonstrates benefits of Vitamin E and C supplementation during combination therapy. These vitamins appear to protect cells from damage typically incurred from conventional Hepatitis C therapy....

Hepatitis B
Title: Hepatitis BCategory: Diseases and ConditionsCreated: 1/26/2001 11:58:00 AMLast Editorial Review: 9/21/2005

Hep C Virus - Health Tip: Nail Salon Safety


Health Tip: Nail Salon Safety
Title: Health Tip: Nail Salon SafetyCategory: Health NewsCreated: 4/12/2005 1:59:00 AMLast Editorial Review: 4/12/2005 1:58:31 AM

Pill Form of Therapy for HCV Coming Closer
This report is an update of therapy progress presented at the AASLD (American Academy for the Study of Liver Diseases). Three separate approaches are covered. Yes, progress is being made....

Shorter Therapy Effective for Genotypes 2 and 3
Genotypes 2 and 3 are much more responsive to current interferon combination therapies. This report details studies that show a shorter course of treatment might be just as effective as longer courses. Researchers continue to refine treatment protocols for HCV...

Two Studies Recruiting HCV Patients
Sho-saiko-to is the number one liver remedy in Japan. It has been prescribed to over 1.5 million patients (in Japan, doctors medically prescribe certain natural remedies, just like doctors prescribe pharmaceutical drugs in the U.S.). Based on the large body...

Cirrhosis Of The Liver
Title: Cirrhosis Of The LiverCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 12/1/2005

Monday, February 13, 2006


Hep C Virus - AW! Print Hep C


AW! Print Hep C
... that anywhere from 80-90% of injection drug users have been infected with the Hep C virus. It is usually spread by ...

The Body: Diagnosis and Monitoring Hepatitis C Infection
Diagnosis and Monitoring Hepatitis C Infection, at The Body, the complete HIV/AIDS resource. ... The qualitative PCR won't tell you how many HEP C virus particles there are in your blood sample but it will tell you ...

Hepatology: Milk Thistle dosage for Hep C
... like chirosis, and a contiuing increase in live Hep-C virus. By helping the liver to heal itself ... actulally aid in destroying the Hep-C virus and there is no ...

Hep C Virus - PharmaCare Pharmacy - HCV | HCV Basics -An overview of HCV, its


PharmaCare Pharmacy - HCV | HCV Basics -An overview of HCV, its
HCV Clinical Resource Name: Phone: Best Time To Call: A PharmaCare representative will call to assist you and answer your questions. We will leave a brief message if you are unavailable at the time of our

Hepatitis C: FAQ | CDC Viral Hepatitis
a) Anti-HCV (antibody to HCV) EIA (enzyme immunoassay) or CIA (enhanced chemiluminescence immunoassay) Test is usually done first. If positive, it should be

Viropharma Incorporated | Therapeutic Focus | HCV-796
virus (HCV). Together with Wyeth, ViroPharma has discovered multiple, chemically distinct compound series that target the RNA replication process (RNA Polymerase) of HCV. The current focus of the

Sunday, February 12, 2006


Hep C Virus - Hepatitis C Treatment Alternatives: hbv_research (Hepatitis C Treatment Alternatives)


Hepatitis C Treatment Alternatives: hbv_research (Hepatitis C Treatment Alternatives)
... in the treatment of mutant type chronic viral heaptitis B 23-Oct-2002 Hepatitis C and Hepatitis ... Berquist KR, London WT. 1975. Viral heaptitis, type B in experimental animals ...

ILAR Journal Online, Volume 42(2) 2001: Animal Models of Hepatitis
... LF, Maynard JE, Purcell RH, Hoofnagle JH, Berquist KR, London WT. 1975. Viral heaptitis, type B in experimental animals ...

Hepatitis C and Hepatitis B Virus Infection in Different Hemodialysis Un
... the efficacy of interferon in the treatment of mutant type chronic viral heaptitis B. Return to Table of Contents ...

Hep C Virus - Ways You Can Get Infected With Hepatitis C(NC)-Hepatitis

Ways You Can Get Infected With Hepatitis C

(NC)-Hepatitis C is spread through contact with infected blood. Here are just some of the ways in which you can be infected with this virus:

Sharing needles, straws, pipes, spoons and other drug-related equipment.

(At least two-thirds of all new hepatitis C infections are drug-use related. Cleaning equipment with bleach does not always effectively kill the virus) p>

Getting a tattoo, body piercing or acupuncture from an operator who does not use sterile equipment or techniques

Being born to a mother with hepatitis C

Getting pierced by a needle or sharp equipment that has infected blood on it ( in a hospital, workplace situation, etc.) p>

People who had blood transfusions before the testing of blood donations became mandatory in 1990 may also be at risk. And, while the risk is low, it is also possible to become infected by sharing personal household articles such as a razor or toothbrush with an infected person. The risk of transmission of hepatitis C during sex is also low, unless both parties have open bleeding sores.

It is estimated that 240, 000 people in Canada are currently infected with hepatitis C, of whom only 30% know they have the virus.

If you think you may be at risk, either now or from past risky activities see a doctor. The virus can be detected with a simple blood test, and there are steps and medications you can take to successfully minimize the effects of the disease if your diagnosis is positive. For more information, visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.



Hep C Virus - PATHOPHYSIOLOGY of HEPATITIS C


PATHOPHYSIOLOGY of HEPATITIS C
... and ductule tissues then undergo inflammatory changes. The Hep C virus is not sufficient to destroy or damage liver ...

maulana azad medical college, medical college, medical hosptial
Name Of The Project. Name of the PI & Department. Funding Agency. 1. Significance of Genotypic Characterization of Hep.C Virus isolates. Dr. A. Chakravarty, Prof. of Microbiology. UGC. 2. ... Hep.C Virus infection during Pregnancy and its effect on the course of outcome of pregnancy ...

VETERANS (especially Viet Nam) and Hep C - BrainTalk Communities
... reveals the Hep C antibody, then a second blood test is performed to detect whether the active Hep C virus is present ...

Deadly Hep-C Could Be Passed By Kissing
Deadly Hep-C Could. Be Passed By Kissing. By Maxine Frith. Social Affairs Correspondent. The Independent - UK. 9-30-3. The potentially fatal hepatitis C virus can be passed on more easily than doctors have thought, a study shows.